ATM and B-cell chronic lymphocytic leukemia: These studies have demonstrated that TP53 and ATM defects can be either clonal or subclonal, with the former representing genomic events that have arisen early during CLL development, while the latter corresponds to later events that emerge as a result of clonal selection pressures [25].